PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 120 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q1 2015. The put-call ratio across all filers is 3.07 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $148,000 | -50.5% | 141,260 | +39.4% | 0.01% | -50.0% |
Q4 2015 | $299,000 | +94.2% | 101,360 | +108.3% | 0.01% | +100.0% |
Q3 2015 | $154,000 | -31.2% | 48,660 | +28.4% | 0.01% | -16.7% |
Q2 2015 | $224,000 | -49.1% | 37,900 | -7.9% | 0.01% | -50.0% |
Q1 2015 | $440,000 | – | 41,150 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Avoro Capital Advisors LLC | 1,134,578 | $10,654,000 | 7.22% |
Consonance Capital Management LP | 3,427,789 | $32,187,000 | 4.15% |
ACUTA CAPITAL PARTNERS, LLC | 604,075 | $5,672,000 | 3.83% |
KOPP INVESTMENT ADVISORS LLC | 758,233 | $7,119,000 | 3.42% |
Aisling Capital LLC | 2,010,000 | $18,874,000 | 2.86% |
Broadfin Capital, LLC | 6,100,000 | $57,280,000 | 2.49% |
THOMPSON DAVIS & CO., INC. | 154,760 | $1,453,000 | 1.68% |
RUDMAN ERROL M | 300,000 | $2,817,000 | 1.14% |
WALL STREET ASSOCIATES | 1,259,500 | $11,827,000 | 1.13% |
Timpani Capital Management LLC | 291,377 | $2,736,000 | 1.08% |